← Back
$CRBP All transactions

Corbus Pharmaceuticals Holdings, Inc.

A 10b5-1 Plan

$ Value

$0

Shares

16,000

Price

$0

Filed

Jun 2

Insider

Name

Jenkins John Kenneth

Title

CIK

0001742557

Roles

Director

Transaction Details

Transaction Date

2025-05-30

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,000

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2024. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.21 to $7.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | On May 30, 2025, 4,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant. | This amount includes 4,800 unvested RSUs that were granted on May 30, 2025. | The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.

Filing Info

Accession No.

0000950170-25-080311

Form Type

4

Issuer CIK

0001595097

Jenkins John Kenneth's History

Date Ticker Type Value
2025-05-30 CRBP $20K
2025-05-30 CRBP A $0
2025-05-30 CRBP A $0

Other Insiders at CRBP (90d)

Insider Bought Sold Last
Moran Sean F.
Chief Financial Officer
$37K 2026-02-13
Cohen Yuval
Chief Executive Officer
$108K 2026-02-13
Smethurst Dominic
Chief Medical Officer
$77K 2026-03-02
Hodgson Ian
Chief Operating Officer
$26K 2026-02-17